JP2025506203A5 - - Google Patents

Info

Publication number
JP2025506203A5
JP2025506203A5 JP2024547850A JP2024547850A JP2025506203A5 JP 2025506203 A5 JP2025506203 A5 JP 2025506203A5 JP 2024547850 A JP2024547850 A JP 2024547850A JP 2024547850 A JP2024547850 A JP 2024547850A JP 2025506203 A5 JP2025506203 A5 JP 2025506203A5
Authority
JP
Japan
Prior art keywords
amino acid
antibody
her2
polypeptide
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547850A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506203A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062260 external-priority patent/WO2023154780A1/en
Publication of JP2025506203A publication Critical patent/JP2025506203A/ja
Publication of JP2025506203A5 publication Critical patent/JP2025506203A5/ja
Pending legal-status Critical Current

Links

JP2024547850A 2022-02-09 2023-02-09 抗ｈｅｒ２／ｎｅｕ抗体および使用方法 Pending JP2025506203A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263267755P 2022-02-09 2022-02-09
US63/267,755 2022-02-09
PCT/US2023/062260 WO2023154780A1 (en) 2022-02-09 2023-02-09 Anti-her2/neu antibodies and methods of use

Publications (2)

Publication Number Publication Date
JP2025506203A JP2025506203A (ja) 2025-03-07
JP2025506203A5 true JP2025506203A5 (cg-RX-API-DMAC7.html) 2026-03-27

Family

ID=86054158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547850A Pending JP2025506203A (ja) 2022-02-09 2023-02-09 抗ｈｅｒ２／ｎｅｕ抗体および使用方法

Country Status (5)

Country Link
US (1) US20250180565A1 (cg-RX-API-DMAC7.html)
EP (1) EP4476265A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506203A (cg-RX-API-DMAC7.html)
CN (1) CN119053627A (cg-RX-API-DMAC7.html)
WO (1) WO2023154780A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
WO2022221877A2 (en) * 2021-04-16 2022-10-20 Martell Diagnostic Laboratories, Inc. Lateral flow analysis and breast cancer

Similar Documents

Publication Publication Date Title
WO2022087293A1 (en) Methods and systems for detecting coronavirus
CN102971343B (zh) 用于癌症诊断和/或预后的新型抗体
JP2018511319A5 (cg-RX-API-DMAC7.html)
EP2363471B1 (en) Immunoassay method for human cxcl1 protein
JP2018518151A5 (cg-RX-API-DMAC7.html)
JP2023527937A5 (cg-RX-API-DMAC7.html)
JP2009541204A5 (cg-RX-API-DMAC7.html)
CN112105644B (zh) 针对人pd-l1和pd-l2的双重特异性抗体及其使用方法
JP2016500659A5 (cg-RX-API-DMAC7.html)
JP7557023B2 (ja) 多発性骨髄腫におけるｍタンパク質反応の臨床評価
CN113214393A (zh) Il-6抗体或其抗原结合片段及包含其的检测试剂盒
CN108700586A (zh) 用于评估癌症发生的风险的组合物和方法
JP2024534348A5 (cg-RX-API-DMAC7.html)
KR102058150B1 (ko) 담도 세포에서 메티오닐-티알엔에이 합성효소를 이용한 담도암 진단 방법
JP2025506203A5 (cg-RX-API-DMAC7.html)
US11009507B2 (en) Methods and diagnostics for cancer detection and treatment monitoring
CN111316102A (zh) 使用甲硫氨酰-tRNA合成酶诊断胰腺癌的方法以及利用其的胰腺癌诊断试剂盒
JP2023527771A (ja) 抗ヒトｌａｇ－３抗体および免疫組織化学（ｉｈｃ）でのその使用
JP2020515286A5 (cg-RX-API-DMAC7.html)
JP7593669B2 (ja) コンパニオン診断用バイオマーカー組成物およびこれを含むコンパニオン診断用キット
JP2024544885A5 (cg-RX-API-DMAC7.html)
CN116836291B (zh) 抗cd47-cldn18.2双特异性抗体的抗独特型抗体及其制备方法和应用
TWI869740B (zh) 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒
CN112724253B (zh) 抗人穹窿体蛋白的抗体及其应用
JP2025510594A5 (cg-RX-API-DMAC7.html)